aod9604 supplementation intent purpose AOD-9604 5mg (Spray) – Modified Aminos AOD-9064 Fat-Metabolizing Peptide Fragment WHAT

Designed for researchers investigating advanced cellular pathways, this formulation features 5-Amino-1-methylquinolinium, a potent small molecule inhibitor of the enzyme Nicotinamide N-methyltransferase (NNMT)

General recommendations are for 2.4 micrograms (mcg) a day, although those who are elderly or breastfeeding women may need more

As shown in Table 1 and Figure 6, the small molecule inhibitors targeting NNMT can be categorized into SAM-competitive inhibitors, NAM-competitive inhibitors, Dual-substrate-competitive inhibitors and isomerization inhibitors

Regulatory Status of Peptide Compounding in 2025

Heres what you need to know: Standard Dose: 250-500 mcg (0.25-0.5 mg) once daily via subcutaneous injection Clinical Range: Research protocols tested 250 mcg to 1 mg daily with no additional benefit above 1 mg Timing: Morning administration in completely fasted state for optimal lipolytic effect Administration: Subcutaneous injection into abdominal fat region Cycle Length: Typically 12-24 weeks based on metabolic goals and physician guidance Reconstitution: Mixed with bacteriostatic water

For broader pricing context, see Peptide Pricing in Canada and Why Some Peptides Cost More Than Others